The Assessment of Movement Disorders Utilizing Live Two-Way Video
This study has been completed.
Information provided by (Responsible Party):
Sandeep kapoor, Northwell Health
First received: October 31, 2011
Last updated: September 19, 2016
Last verified: September 2016
The purpose of this project is to determine the equivalency of extrapyramidal symptoms (EPS) and tardive dyskinesia (TD) examinations conducted via live two-way video versus live examinations completed in-person
Other: Two way video assessment
||Observational Model: Case-Only
Time Perspective: Cross-Sectional
||The Assessment of Movement Disorders Utilizing Live Two-Way Video
Primary Outcome Measures:
- Abnormal Involuntary Movement Scale (AIMS) when done in-person versus via two-way video [ Time Frame: Baseline ]
- Modified Simpson Angus Scale (mSAS) short version when done in-person versus via two-way video [ Time Frame: Baseline ]
Secondary Outcome Measures:
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||June 2016 (Final data collection date for primary outcome measure)
Inclusion Criteria: Inpatients and outpatients aged 18-75 years old who have been taking antipsychotics for longer than 6 months in their life time, and that have been compliant for the past week. Patients will be referred by their treating doctors if they have some evidence of movement disorder based on the physician's clinical judgment. We will also include 25% of the sample without any evidence of movement disorder.
Exclusion Criteria: Patients who have medical conditions which make it difficult to perform a physical examination. Patients who are clinically too ill to consent and/or unable to cooperate with the examination procedures.
Other: Two way video assessment
Participants will be assessed extrapyramidal symptoms and tardive dyskinesia
Extrapyramidal symptoms (EPS) and tardive dyskinesia (TD) are one of the most frequent and troublesome adverse events when taking antipsychotic agents. The investigators aim in this study to determine if the investigators can conduct examinations for EPS and TD remotely using live two-way video. It is potentially beneficial for patients, especially those who are located far away from psychiatrists if they could be seen by trained clinicians and assessed for EPS and TD via two-way video in the future. Participants will be asked to have a medical assessment which consists of simple questions and some examination of their movements via two-way video and in person. The investigators will compare the results of video examinations with the results of live examinations.
|Ages Eligible for Study:
||18 Years to 75 Years (Adult, Senior)
|Sexes Eligible for Study:
|Accepts Healthy Volunteers:
40 patients with schizophrenia will be recruited via in- and outpatient psychiatry service of The Zucker Hillside Hospital.
- Inpatients and outpatients aged 18-75 years old who have been taking antipsychotics for longer than 6 months in their life time, and
- That have been compliant for the past week.
- Patients who have medical conditions which make it difficult to perform a physical examination.
- Patients who are clinically too ill to consent and/or unable to cooperate with the examination procedures.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01467089
|The Zucker Hillside Hospital
|Glen Oaks, New York, United States, 11004 |
||Sandeep Kapoor, MD
||Sandeep kapoor, Principal Investigator, Northwell Health
History of Changes
|Other Study ID Numbers:
|Study First Received:
||October 31, 2011
||September 19, 2016
Keywords provided by Sandeep kapoor, Northwell Health:
Two Way Video Assessment
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on September 21, 2017
Central Nervous System Diseases
Nervous System Diseases
Signs and Symptoms